ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $534K of Zentalis Pharmaceuticals, Inc.
Sold$534,474
$53.45Price
10,000Shares
−3%Stake
What ZNTL did after the filing
- The stock from Tue, Feb 8 open, $53.00
- −8.3%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Mar 23 close.
Traded Mon, Feb 7. Filed Mon, Feb 7, 4:53 PM ET, after the close. Returns use the Feb 8 open and the Mar 23 close. Not investment advice.